Передові методи діагностики хронічної хвороби нирок у дітей в країнах, що розвиваються: огляд літератури

  • IK Ndu Госпіталь Державного технологічного університету Енугу https://orcid.org/0000-0003-2198-5614
  • SR Ohayi Госпіталь Державного технологічного університету Енугу
  • BO Edelu Університетська лікарня Університету Нігерії
DOI: https://doi.org/10.31450/ukrjnd.3(71).2021.08
Ключові слова: діагностичні методи, педіатрична хронічна хвороба нирок

Анотація

Резюме: Хронічна хвороба нирок (ХХН) є тяжким прогресуючим захворюванням, яке може ускладнювати перебіг як неінфекційних захворювань, так і інфекційних захворювань. Приблизно десята частина дорослого населення світу страждає на ХХН, але поширеність ХХН у дітей залишається невідомою. На жаль, передові методи діагностики та лікування недоступні у більшості країн, що розвиваються. Цей огляд має на меті підвищити обізнаність щодо ХХН у Нігерії та активізувати зусилля, спрямовані на покращення доступності нових діагностичних та лікувальних підходів.

Завантаження

Дані завантаження ще не доступні.

Посилання

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.

Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118(3):c269-77. doi:10.1159/000321382.

Schaefer F, Borzych-Duzalka D, Azocar M, Munarriz RL, Sever L, Aksu N, et al. Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int. 2012;32(4):399-409. doi:10.3747/pdi.2012.00126.

Vachvanichsanong P, Dissaneewate P, McNeil E. Childhood chronic kidney disease in a developing country. Pediatr Nephrol. 2008;23(7):1143-7. doi: 10.1007/s00467-008-0775-4.

Harambat J, Ekulu PM. Inequalities in access to pediatric ESRD care: a global health challenge. Pediatr Nephrol. 2016;31(3):353-8. doi:10.1007/s00467-015-3263-7.

Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950-7. doi:10.1038/ki.2015.230.

Staples A, Wong C. Risk factors for progression of chronic kidney disease. Curr Opin Pediatr. 2010;22(2):161-169. doi:10.1097/MOP.0b013e328336ebb0.

Ardissino G, Daccò V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F; ItalKid Project. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics. 2003;111(4 Pt 1):e382-7. doi:10.1542/peds.111.4.e382.

Soylemezoglu O, Duzova A, Yalçinkaya F, Arinsoy T, Süleymanlar G. Chronic renal disease in children aged 5-18 years: a population-based survey in Turkey, the CREDIT-C study. Nephrol Dial Transplant. 2012;27 Suppl 3:iii146-51. doi: 10.1093/ndt/gfs366.

Bukabau JB, Makulo JR, Pakasa NM, Cohen EP, Lepira FB, Kayembe PK, et al. Chronic kidney disease among high school students of Kinshasa. BMC Nephrol. 2012;13:24. doi:10.1186/1471-2369-13-24.

Ladapo TA, Esezobor CI, Lesi FE. Pediatric kidney diseases in an African country: prevalence, spectrum and outcome. Saudi J Kidney Dis Transpl. 2014;25(5):1110-6. doi:10.4103/1319-2442.139976.

Baum M. Overview of chronic kidney disease in children. Curr Opin Pediatr. 2010;22(2):158-160. doi:10.1097/MOP.0b013e32833695cb.

Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, et al. Acute kidney injury: an increasing global concern. Lancet. 2013 Jul 13;382(9887):170-9. doi:10.1016/S0140-6736(13)60647-9.

Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22(12):1999-2009. doi:10.1007/s00467-006-0410-1.

Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, et al. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005;2(5):e133. doi:10.1371/journal.pmed.0020133.

Sumaili EK, Cohen EP, Zinga CV, Krzesinski JM, Pakasa NM, Nseka NM. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18. doi:10.1186/1471-2369-10-18.

Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53(1):166-74. doi:10.1053/j.ajkd.2007.10.047.

Haileamlak A. Chronic Kidney Disease is on the Rise. Ethiop J Health Sci. 2018;28(6):681-682. doi:10.4314/ejhs.v28i6.1.

Vehaskari VM, Woods LL. Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol. 2005;16(9):2545-56. doi:10.1681/ASN.2005030300.

Baum M. Role of the kidney in the prenatal and early postnatal programming of hypertension. Am J Physiol Renal Physiol. 2010;298(2):F235-F247. doi:10.1152/ajprenal.00288.2009.

Vehaskari VM. Prenatal programming of kidney disease. Curr Opin Pediatr. 2010;22(2):176-82. doi:10.1097/MOP.0b013e328336ebc9.

Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003;111(6 Pt 1):1416-21. doi:10.1542/peds.111.6.1416.

Schwartz GJ, Furth S, Cole SR, Warady B, Muñoz A. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int. 2006 Jun;69(11):2070-7. doi:10.1038/sj.ki.5000385.

Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2006;1(5):1006-15. doi:10.2215/CJN.01941205.

Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, Daina E, Remuzzi G. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol. 1995;6(2):257-63. doi:10.1681/ASN.V62257.

Gaspari F, Thakar S, Carrara F, Perna A, Trillini M, Aparicio MC, et al. Safety of Iohexol Administration to Measure Glomerular Filtration Rate in Different Patient Populations: A 25-Year Experience. Nephron. 2018;140(1):1-8. doi:10.1159/000489898.

Mubarak M. Practicing quality nephropathology in a developing country; challenges and solutions. J Nephropathol. 2015;4(3):59-61. doi:10.12860/jnp.2015.12.

Furness PN, Kazi JI. Laboratory investigation of renal biopsy specimen. J Nephrol Urol Transplant. 1998;1(1):19-26.

Mubarak M. Practicing quality nephropathology in a developing country; challenges and solutions. J Nephropathol. 2015;4(3):59-61. doi:10.12860/jnp.2015.12.

Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27(3):363-73. doi:10.1007/s00467-011-1939-1. Erratum in: Pediatr Nephrol. 2012;27(3):507.

Asinobi AO, Ademola AD, Ogunkunle OO, Mott SA. Paediatric end-stage renal disease in a tertiary hospital in South West Nigeria. BMC Nephrol. 2014;15:25. doi:10.1186/1471-2369-15-25.

Spearman CW, McCulloch MI. Challenges for paediatric transplantation in Africa. Pediatr Transplant. 2014;18(7):668-74. doi: 10.1111/petr.12333.

Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J. 2016;9(4):583-91. doi:10.1093/ckj/sfw047.

Matovinović MS. 1. Pathophysiology and Classification of Kidney Diseases. EJIFCC. 2009;20(1):2-11.

Rees L, Mak RH. Nutrition and growth in children with chronic kidney disease. Nat Rev Nephrol. 2011;7(11):615-23. doi: 10.1038/nrneph.2011.137.

Kaspar CD, Bholah R, Bunchman TE. A Review of Pediatric Chronic Kidney Disease. Blood Purif. 2016;41(1-3):211-7. doi:10.1159/000441737.

Seikaly MG, Salhab N, Gipson D, Yiu V, Stablein D. Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatric Nephrology. 2006 Jun;21(6):793-9. doi: 10.1007/s00467-006-0040-7.

Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA. Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant. 2007;11(4):366-73. doi:10.1111/j.1399-3046.2007.00704.x.

Gat-Yablonski G, Phillip M. Nutritionally-induced catch-up growth. Nutrients. 2015;7(1):517-551. doi:10.3390/nu7010517.

Farquharson C, Ahmed SF. Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH/IGF-1 signaling. Pediatr Nephrol. 2013;28(4):547-56. doi:10.1007/s00467-012-2271-0.

Mitch WE, Price SR. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Ren Nutr. 2003 Apr 1;13(2):149-52. doi: 10.1053/jren.2003.50019.

Quigley R. Chronic kidney disease: highlights for the general pediatrician. Int J Pediatr. 2012;2012:943904. doi:10.1155/2012/943904.

Silverstein DM. Growth and Nutrition in Pediatric Chronic Kidney Disease. Front Pediatr. 2018;6:205. doi:10.3389/fped.2018.00205.

Franke D, Winkel S, Gellermann J, Querfeld U, Pape L, Ehrich JH, Haffner D, Pavičić L, Zivičnjak M. Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol. 2013;28(10):2043-51. doi:10.1007/s00467-013-2502-z.

Wesseling-Perry K, Salusky IB. Chronic kidney disease: mineral and bone disorder in children. Semin Nephrol. 2013;33(2):169-79. doi:10.1016/j.semnephrol.2012.12.017.

Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis. 2012;60(6):1002-11. doi:10.1053/j.ajkd.2012.07.018.

KDOQI; National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47(5 Suppl 3):S11-145. doi: 10.1053/j.ajkd.2006.03.010. Erratum in: Am J Kidney Dis. 2006;48(3):518.

Ratcliffe LE, Thomas W, Glen J, Padhi S, Pordes BA, Wonderling D, Connell R, Stephens S, Mikhail AI, Fogarty DG, Cooper JK, Dring B, Devonald MA, Brown C, Thomas ME. Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale. Am J Kidney Dis. 2016;67(4):548-58. doi:10.1053/j.ajkd.2015.11.012.

Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol. 2008;3(2):457-62. doi:10.2215/CJN.03020707.

Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23(4):578-585. doi:10.1681/ASN.2011111115.

Shroff R, Dégi A, Kerti A, Kis É, Cseprekál O, Tory K, et al. Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol. 2013;28(6):875-84. doi:10.1007/s00467-012-2325-3.

Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol. 2013;24(1):125-35. doi:10.1681/ASN.2012070713.

Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82(4):388-400. doi:10.1038/ki.2012.131.

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 201327;382(9889):339-52. doi:10.1016/S0140-6736(13)60595-4.

Kurella Tamura M, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, et al. Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol. 2016;17:13. doi:10.1186/s12882-016-0226-6.

Wühl E, Schaefer F. Can we slow the progression of chronic kidney disease? Curr Opin Pediatr. 2010;22(2):170-5. doi:10.1097/MOP.0b013e3283360a5c.

Wilson AC, Schneider MF, Cox C, Greenbaum LA, Saland J, White CT, et al. Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(12):2759-65. doi: 10.2215/CJN.03010311.

Ardissino G, Testa S, Daccò V, Paglialonga F, Viganò S, Felice-Civitillo C, et al. Puberty is associated with increased deterioration of renal function in patients with CKD: data from the ItalKid Project. Arch Dis Child. 2012;97(10):885-8. doi:10.1136/archdischild-2011-300685.

Thurman J, Gueler F. Recent advances in renal imaging. F1000Res. 201829;7:F1000 Faculty Rev-1867. doi:10.12688/f1000research.16188.1.

Nadasdy T, Satoskar AA, Silva FG. Adult renal diseases. In: Mills SE, Carter D, Greenson JK, Reuter VE, Stolen MH, editors. Sternberg's diagnostic surgical pathology. Philadelphia: Lippincott Williams and Wilkins; 2010. p. 1681-756.

Naiker IP, Assounga AG, Meyers AM. Diagnostic approach to chronic kidney disease. S Afr Med J. 2015;105(3):236. doi:10.7196/SAMJ.9414.

Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-9. doi: 10.1056/NEJMoa1114248. Erratum in: N Engl J Med. 2012 Aug 16;367(7):681. Erratum in: N Engl J Med. 2012 Nov 22;367(21):2060. 

Bruce R, Wentland AL, Haemel AK, Garrett RW, Sadowski DR, Djamali A, Sadowski EA. Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide. Invest Radiol. 2016;51(11):701-705. doi: 10.1097/RLI.0000000000000259.

Michaely HJ, Aschauer M, Deutschmann H, Bongartz G, Gutberlet M, Woitek R, et al. Gadobutrol in Renally Impaired Patients: Results of the GRIP Study. Invest Radiol. 2017;52(1):55-60. doi: 10.1097/RLI.0000000000000307.

Petcharunpaisan S, Ramalho J, Castillo M. Arterial spin labeling in neuroimaging. World J Radiol. 2010;2(10):384-398. doi:10.4329/wjr.v2.i10.384.

Olowu WA, Adefehinti O, Aladekomo TA. Epidemiology and clinicopathologic outcome of pediatric chronic kidney disease in Nigeria, a single cenetr study. Arab J Nephrol Transplant. 2013;6(2):105-13. 

Odetunde OI, Okafor HU, Uwaezuoke SN, Ezeonwu BU, Adiele KD, Ukoha OM. Chronic kidney disease in children as seen in a tertiary hospital in Enugu, South-East, Nigeria. Niger J Clin Pract. 2014;17(2):196-200. doi: 10.4103/1119-3077.127553.


Переглядів анотації: 448
Завантажень PDF: 18506
Опубліковано
2021-08-05
Як цитувати
Ndu , I., Ohayi, S., & Edelu , B. (2021). Передові методи діагностики хронічної хвороби нирок у дітей в країнах, що розвиваються: огляд літератури. Український Журнал Нефрології та Діалізу, (3(71), 67-75. https://doi.org/10.31450/ukrjnd.3(71).2021.08
Номер
№ 3(71) (2021): Український Журнал Нефрології та Діалізу
Розділ
Школа нефролога